These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

543 related items for PubMed ID: 15277491

  • 1. Role of tumor necrosis factor receptor expression in anterior chamber-associated immune deviation (ACAID) and corneal allograft survival.
    Niederkorn JY, Mayhew E, Mellon J, Hegde S.
    Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2674-81. PubMed ID: 15277491
    [Abstract] [Full Text] [Related]

  • 2. Anterior chamber-associated immune deviation promotes corneal allograft survival.
    Niederkorn JY, Mellon J.
    Invest Ophthalmol Vis Sci; 1996 Dec; 37(13):2700-7. PubMed ID: 8977485
    [Abstract] [Full Text] [Related]

  • 3. Role of CD4+ T cells in immunobiology of orthotopic corneal transplants in mice.
    Yamada J, Kurimoto I, Streilein JW.
    Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2614-21. PubMed ID: 10509657
    [Abstract] [Full Text] [Related]

  • 4. Induction of anterior chamber-associated immune deviation by corneal allografts placed in the anterior chamber.
    Yamada J, Streilein JW.
    Invest Ophthalmol Vis Sci; 1997 Dec; 38(13):2833-43. PubMed ID: 9418737
    [Abstract] [Full Text] [Related]

  • 5. Effect of cyclosporine on anterior chamber-associated immune deviation with retinal transplantation.
    Ishioka M, Okamoto S, Streilein JW, Jiang LQ.
    Invest Ophthalmol Vis Sci; 1997 Sep; 38(10):2152-60. PubMed ID: 9331279
    [Abstract] [Full Text] [Related]

  • 6. Correlation of anterior chamber-associated immune deviation with suppression of corneal epithelial rejection in mice.
    Yao YF, Inoue Y, Miyazaki D, Hara Y, Shimomura Y, Tano Y, Ohashi Y.
    Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):292-300. PubMed ID: 9040461
    [Abstract] [Full Text] [Related]

  • 7. Interleukin-1 receptor antagonist therapy and induction of anterior chamber-associated immune deviation-type tolerance after corneal transplantation.
    Yamada J, Zhu SN, Streilein JW, Dana MR.
    Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4203-8. PubMed ID: 11095616
    [Abstract] [Full Text] [Related]

  • 8. Fate of orthotopic corneal allografts in eyes that cannot support anterior chamber-associated immune deviation induction.
    Sano Y, Ksander BR, Streilein JW.
    Invest Ophthalmol Vis Sci; 1995 Oct; 36(11):2176-85. PubMed ID: 7558710
    [Abstract] [Full Text] [Related]

  • 9. Effect of alloantibodies on corneal allograft survival.
    Hegde S, Mellon JK, Hargrave SL, Niederkorn JY.
    Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1012-8. PubMed ID: 11923241
    [Abstract] [Full Text] [Related]

  • 10. CD4+ T-cell-independent rejection of corneal allografts.
    Niederkorn JY, Stevens C, Mellon J, Mayhew E.
    Transplantation; 2006 Apr 27; 81(8):1171-8. PubMed ID: 16641604
    [Abstract] [Full Text] [Related]

  • 11. Immunologic mechanisms of corneal allografts reconstituted from cultured allogeneic endothelial cells in an immune-privileged site.
    Hayashi T, Yamagami S, Tanaka K, Yokoo S, Usui T, Amano S, Mizuki N.
    Invest Ophthalmol Vis Sci; 2009 Jul 27; 50(7):3151-8. PubMed ID: 19255161
    [Abstract] [Full Text] [Related]

  • 12. Effect of anterior chamber-associated immune deviation (ACAID) on rat islet allograft rejection.
    Koevary SB, Beaudry K.
    Ocul Immunol Inflamm; 2000 Mar 27; 8(1):39-47. PubMed ID: 10806433
    [Abstract] [Full Text] [Related]

  • 13. T cell subsets in the immune rejection of murine heterotopic corneal allografts.
    Matoba AY, Peeler JS, Niederkorn JY.
    Invest Ophthalmol Vis Sci; 1986 Aug 27; 27(8):1244-54. PubMed ID: 2942516
    [Abstract] [Full Text] [Related]

  • 14. Anterior chamber inoculation of splenocytes without Fas/Fas-ligand interaction primes for a delayed-type hypersensitivity response rather than inducing anterior chamber-associated immune deviation.
    Kawashima H, Yamagami S, Tsuru T, Gregerson DS.
    Eur J Immunol; 1997 Oct 27; 27(10):2490-4. PubMed ID: 9368601
    [Abstract] [Full Text] [Related]

  • 15. ACAID induced by allogeneic corneal tissue promotes subsequent survival of orthotopic corneal grafts.
    Sonoda A, Sonoda Y, Muramatu R, Streilein JW, Usui M.
    Invest Ophthalmol Vis Sci; 2000 Mar 27; 41(3):790-8. PubMed ID: 10711695
    [Abstract] [Full Text] [Related]

  • 16. [The effect of TNF-related apoptosis-inducing ligand on in vivo graft survival after ex vivo adenovirus-mediated gene transfer to cornea].
    Guo P, Xie LX, Shi WY, Li XX.
    Zhonghua Yan Ke Za Zhi; 2003 Jan 27; 39(1):19-23. PubMed ID: 12760808
    [Abstract] [Full Text] [Related]

  • 17. Immune privilege and immunogenicity reside among different layers of the mouse cornea.
    Hori J, Joyce NC, Streilein JW.
    Invest Ophthalmol Vis Sci; 2000 Sep 27; 41(10):3032-42. PubMed ID: 10967061
    [Abstract] [Full Text] [Related]

  • 18. CD4+PD-1+ T cells acting as regulatory cells during the induction of anterior chamber-associated immune deviation.
    Meng Q, Yang P, Li B, Zhou H, Huang X, Zhu L, Ren Y, Kijlstra A.
    Invest Ophthalmol Vis Sci; 2006 Oct 27; 47(10):4444-52. PubMed ID: 17003438
    [Abstract] [Full Text] [Related]

  • 19. Characterization of the suppressor cell(s) responsible for anterior chamber-associated immune deviation (ACAID) induced in BALB/c mice by P815 cells.
    Streilein JW, Niederkorn JY.
    J Immunol; 1985 Mar 27; 134(3):1381-7. PubMed ID: 3155766
    [Abstract] [Full Text] [Related]

  • 20. Latanoprost does not affect immune privilege of corneal allografts.
    Wang M, Kitahara Y, Yoshida A, Hori J.
    Exp Eye Res; 2008 Feb 27; 86(2):394-402. PubMed ID: 18187130
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.